Cat. No. | Product name | CAS No. |
DC47237 |
PD 102807
Featured
PD 102807 is a M4 muscarinic receptor antagonist with an IC50 of 90.7 nM. PD 102807 inhibits M1, M2, M3, M5 muscarinic receptor with IC50s of 6558.7, 3440.7, 950.0, and 7411.7 nM, respectively. Antidyskinetic effect. |
23062-91-1 |
DC47259 |
Inarigivir ammonium
Featured
Inarigivir (ORI-9020) ammonium is a dinucleotide antiviral drug which can significantly reduce liver HBV DNA in transgenic mice expressing hepatitis B virus. Inarigivir (ORI-9020) act as an RIG-I agonist to activate cellular innate immune responses. |
2172788-92-8 |
DC47260 |
Zunsemetinib
Featured
Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases. |
1640282-42-3 |
DC47269 |
Samuraciclib
Featured
Samuraciclib (CT7001) is a potent, selective, ATP-competitive and orally active CDK7 inhibitor, with an IC50 of 41 nM. Samuraciclib displays 45-, 15-, 230- and 30-fold selectivity over CDK1, CDK2 (IC50 of 578 nM), CDK5 and CDK9, respectively. Samuraciclib inhibits the growth of breast cancer cell lines with GI50 values between 0.2-0.3 µM. Samuraciclib has anti-tumor effects. |
1805833-75-3 |
DC47270 |
(S)-Amisulpride
Featured
(S)-Amisulpride (Esamisulpride) is a potent dopamine D2/D3 receptor antagonist. (S)-Amisulpride is an antagonist at the 5-HT7 receptor with a KI of 900 nM. (S)-Amisulpride has antipsychotic and antidepressant effects. |
71675-92-8 |
DC47315 |
ML-SI3
Featured
ML-SI3 is a potent TRPML channel inhibitor with IC50s of 4.7 µM and 1.7 µM for TRPML1 and TRPML2, respectively. |
891016-02-7 |
DC47316 |
LOX-IN-3 Dihydrochloride
Featured
LOX-IN-3 Dihydrochloride is an orally active and selective lysyl oxidase (LOX) inhibitor. |
2409964-23-2 |
DC47318 |
7,12-Dimethylbenz[a]anthracene (DMBA)
Featured
7,12-Dimethylbenz[a]anthracene (DMBA) is an immunosuppressor as well as a potent organ-specific carcinogen. |
57-97-6 |
DC60155 |
Lu AF27139
Featured
Lu AF27139 is a novel rodent-active and CNS-penetrant P2X7 receptor antagonist. Lu AF27139 is highly selective and potent against rat, mouse, and human forms of the receptors. The rat pharmacokinetic profile is favorable with high oral bioavailability, modest clearance (0.79 L/(h kg)), and good CNS permeability. Importantly, Lu AF27139 was without effect in standard in vitro and in vivo toxicity studies. Lu AF27139 is a valuable tool for probing the role of the P2X7 receptor in rodent models of CNS diseases. |
2097117-06-9 |
DC60156 |
Rasarfin
Featured
Rasarfin is a novel dual Ras and ARF6 inhibitor. Rasarfin blocks agonist-mediated internalization of AT1R and other GPCRs. Rasarfin also potently inhibits agonist-induced ERK1/2 signaling by GPCRs, and MAPK and Akt signaling by EGFR, as well as prevents cancer cell proliferation. In silico modeling and in vitro studies reveal a unique binding modality of Rasarfin within the SOS-binding domain of Ras. Rasarfin is a novel dual Ras and ARF6 inhibitor. Rasarfin blocks agonist-mediated internalization of AT1R and other GPCRs. Rasarfin also potently inhibits agonist-induced ERK1/2 signaling by GPCRs, and MAPK and Akt signaling by EGFR, as well as prevents cancer cell proliferation. In silico modeling and in vitro studies reveal a unique binding modality of Rasarfin within the SOS-binding domain of Ras. |
674359-73-0 |
DC60157 |
KYN101
Featured
KYN-101 is a novel potent and selective inhibitor of aryl hydrocarbon receptor (AHR) (IC50 of 22 nM in the human HepG2 DRE-luciferase reporter assay and 23 nM in the murine Hepa1 Cyp-luc assay). |
|
DC60158 |
K-975
Featured
K-975 is a first-in-class TEAD inhibitor, directly inhibiting YAP/TAZ-TEAD protein-protein interaction and showing a potent anti-tumor effect in malignant pleural mesothelioma. K-975 was covalently bound to an internal cysteine residue located in the palm |
2563855-03-6 |
DC60159 |
Azo-Resveratrol
Featured
Azo-Resveratrol is an analog of Resveratrol used as a potent tyrosinase inhibitor. |
1393556-48-3 |
DC60160 |
Homo-VK-II-36
Featured
Homo-VK-II-36 is a carvedilol analogue. It acts by inhibiting store-overload-induced calcium release (SOICR) through the RyR2 channel. |
|
DC60161 |
NSC2805
Featured
NSC-2805 is a WWP2 ubiquitin ligase inhibitor. |
4371-34-0 |
DC60162 |
GPR52-IN-43(CAY10786)
Featured
GPR52-IN-43(CAY10786) is a novel GPR52 antagonist, reducing mHTT levels by targeting GPR52 and promoting survival of mouse primary striatal neurons, and also reducing HD-related phenotypes in HdhQ140. |
1239987-91-7 |
DC60163 | FPPS-IN-11 Featured | 1250273-31-4 |
DC60165 | DoPAT Featured | 558484-21-2 |
DC60166 | Benzenecarbodithioicacid, phenylmethyl ester Featured | 27249-90-7 |
DC60167 | Benzene, 1-[(1R)-1-(bromomethoxy)ethyl]-3,5-bis(trifluoromethyl)- Featured | 530441-95-3 |
DC60168 | ethyl 2-ethoxycarbothioylsulfanylpropanoate Featured | 73232-07-2 |
DC60169 | 2,3,5,6-tetrahydropentalen-1(4H)-one Featured | 10515-92-1 |